About Us
Fueled by an increasingly interconnected world, population growth and climate change, infectious diseases are a growing threat to public health. Outbreaks can spread rapidly and are responsible for 15 million deaths each year. Now more than ever, effective responses to emerging global health emergencies will require research and optimized infrastructure to support discoveries.
More About Us.jpg)
Featured Lab
Weiqiang (Javier) Chen Lab
The Chen lab studies arboviral infections, including Zika virus and Chikaunguya virus, with a focus on how they cause debilitating bone pathologies.
Learn More
Featured Lab
Suan Sin (Jolin) Foo Lab
The Foo lab researches viral infections during pregnancy, specifically viral pathogensis and maternal-fetal immunology, in emerging pathogens including Zika virus and high-risk SARS-CoV-2.
Learn More
Featured Lab
Frank Xie Lab
The Xie lab studies the structure, dynamics and mechanisms of the regulatory genome in human infectious disease and cancer.
Learn MoreResearch News
Dr. Jae Jung will study the natural course of infection and viral reassortment of the emerging pathogen, Severe Fever with Thrombocytopenia Syndrome Virus (SFTSV).
In this newly created role, he will lead the development of novel vaccine platforms for a variety of infectious diseases, including influenza, HIV and COVID-19.
Dr. Jung and his team of researchers published the novel COVID-19 study, which details the critical role viral gene ORF8 plays in infection and outcomes rates, using samples from Cleveland Clinic’s BioRepository.